The article discusses the latest developments in the operation of GenoLogics, a leading laboratory information management system (LIMS) provider for the next-generation sequencing (NGS) industry, as of March 2011. It cites the partnership signed by the company with Illumina for the sale of the former's LIMS product. The opinion of GenoLogics' Michael Ball on the partnership is also cited.